SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-162509
Filing Date
2015-04-30
Accepted
2015-04-30 17:01:22
Documents
8
Period of Report
2015-06-16
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d913905ddef14a.htm DEF 14A 1023415
2 GRAPHIC g913905g31b98.jpg GRAPHIC 66881
3 GRAPHIC g913905g36i66.jpg GRAPHIC 6692
4 GRAPHIC g913905g45u09.jpg GRAPHIC 53708
5 GRAPHIC g913905g60i22.jpg GRAPHIC 79107
6 GRAPHIC g913905img1.jpg GRAPHIC 6312
7 GRAPHIC g913905img2.jpg GRAPHIC 5188
8 GRAPHIC g913905img3.jpg GRAPHIC 5361
  Complete submission text file 0001193125-15-162509.txt   1333280
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 15819929
SIC: 2834 Pharmaceutical Preparations